Sep 22, 2026
The official launch of the company's new PLATINUM service to provide clients with an all-in-one, fully managed, HIPAA-compliant digital marketing engine.
Los Altos, California, United States, September 22, 2026 -- PatientGain has officially launched its PLATINUM service, an all-in-one, fully managed, HIPAA-compliant digital marketing engine engineered specifically for clinics offering advanced mental health treatments. The platform provides comprehensive marketing solutions for specialized clinics delivering neuroplasticity-based treatments, including Transcranial Magnetic Stimulation (TMS), IV Ketamine, and Spravato, with pricing starting at $1699/month.

Specialized mental health clinics face unique hurdles, including strict regulatory compliance, patient education barriers, and a heavy reliance on a steady pipeline of professional medical referrals. PatientGain's PLATINUM tier directly addresses these industry pain points by pairing healthcare-trained AI agents with expert human project managers and oversight. This hybrid approach ensures that sensitive healthcare marketing campaigns are both highly effective and HIPAA compliant.
"Marketing for cutting-edge treatments like TMS, Ketamine, and Spravato requires a delicate balance of patient education, local medical networking, and strict adherence to healthcare privacy laws," said Sarah Clark, spokesperson for PatientGain. "The PLATINUM tier functions as a complete digital marketing solution that handles the heavy lifting-from educating prospective patients to sending 3 monthly Email campaigns-while maintaining HIPAA and regulatory protection."
Key features of the PatientGain PLATINUM service for specialized Ketamine and Spravato clinics include:
The PLATINUM service is available immediately for medical groups and independent clinics looking to scale their patient acquisition safely and effectively.
For more information about PatientGain use the contact details below:
Contact Info:
Name: PatientGain Team
Email: Send Email
Organization: PatientGain
Website: http://www.patientgain.com
Release ID: 89203469
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.
The two companies settled billing disputes between doctors and insurers, keeping patients out of the middle. One let doctors win 96 percent of the time.
The BBC's economics editor views one more interest rate as likely, but thinks that will be all.
Job, loans and savings are all affected by the rise in interest rates announced by the Bank of England.
Most analysts expected the increase from 3.75% to 4%.
Israeli party leaders were holding discussions with President Isaac Herzog on Thursday about who should get the first chance to form a governing coalition.
The central bank increased interest rates for the first time in more than three years and warned that inflation would climb to about 5 percent next year, far above its target.
The Lone Star State’s business-friendly playbook could be rewritten by the Democrats’ election sweep there.
Some call him a doomer. Others see him as a responsible technologist. Here’s how the Anthropic chief executive’s thinking on artificial intelligence was shaped.
Toyota is cashing in on a U.S. hybrid boom as electric-vehicle demand slows, but shifting political tides in Washington could jeopardize its edge.
Location is not just the only factor on why prices differ across London, as Anna O'Neill finds out.
Chinese authorities stopped the sale of ABB Robotics, owned by a Swiss conglomerate, to SoftBank of Japan amid wider scrutiny of global transactions that could affect Beijing’s technology ambitions.
Is there any city that's more romantic? View Entire Post ›
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.